CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

CRC Health Group Inc.

CRC Health Corporation (CRC) is a provider of substance abuse treatment services and youth treatment services in the United States.

Detroit Institute for Children

Detroit Institute for Children is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

I Know Cpr

I Know Cpr is a Marysville, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Marshall Medical Center

Marshall Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Marshall Medical Center is based in Placerville, CA. You can find more information on Marshall Medical Center at www.marshallmedical.org

The Health and Wellness Institute

The Health and Wellness Institute is a Providence, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.